SEC Form 4 · accession 0001140361-16-056278
INTERPACE BIOSCIENCES, INC. · IDXG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nat Krishnamurti
Officer — Interim CFO
Period of report
Mar 1, 2016
Accepted (ET)
Mar 3, 2016 · 2:47 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001054102
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 8,793 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted stock unitsF1,F2 | — | Mar 1, 2016 | A | 60,000 | A | — | — | Common Stock | 60,000 | 60,000 | D |
Explanation of responses
- F1Each restricted stock unit represents the right to receive, upon vesting, one share of common stock.
- F2Mr. Krishnamurti was awarded 60,000 restricted stock units ("RSUs") upon being named Interim Chief Financial Officer, Treasurer and Secretary. The RSUs vest one-third annually on the anniversary of the date of grant.